$OPGN
OPGEN INC Stock $opgn

$opgn Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000182912624003930 Filed on June 03, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$28.00K	$1.070M	$3.418M
YoY Change	-96.2%	48.24%	31.11%
Cost Of Revenue		$1.178M	$3.084M
YoY Change		119.77%	-7.09%
Gross Profit		-$108.2K	$334.2K
YoY Change		-158.25%	-146.93%
Gross Profit Margin		-10.11%	9.78%
Selling, General & Admin	$1.594M	$1.459M	$10.86M
YoY Change	-55.54%	-54.36%	-17.87%
% of Gross Profit			3250.59%
Research & Development	$22.96K	$329.4K	$4.733M
YoY Change	-98.35%	-78.78%	-42.09%
% of Gross Profit			1415.98%
Depreciation & Amortization		$248.0K	$1.319M
YoY Change		-26.01%	-19.73%
% of Gross Profit			394.5%
Operating Expenses	$1.617M	$1.788M	$15.60M
YoY Change	-67.49%	-62.06%	-27.12%
Operating Profit	-$1.547M	-$1.896M	-$30.75M
YoY Change	-69.99%	-58.12%	-11.05%
Interest Expense	$1.079K	-$85.08K	$1.839M
YoY Change	-99.84%	-85.8%	-43.53%
% of Operating Profit
Other Income/Expense, Net	-$29.04K		-$1.920M
YoY Change	-95.67%		-29.32%
Pretax Income	-$1.576M	-$17.04M	-$32.67M
YoY Change	-72.95%	61.76%	-12.38%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$1.576M	-$17.04M	-$32.67M
YoY Change	-72.95%	61.76%	-12.38%
Net Earnings / Revenue	-5629.82%	-1593.09%	-955.69%
Basic Earnings Per Share			-$41.47
Diluted Earnings Per Share		-$14.42	-$41.47
COMMON SHARES
Basic Shares Outstanding	1.344M shares	10.01M shares	787.8K shares
Diluted Shares Outstanding			787.8K shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments		$1.152M	$1.152M
YoY Change		-84.52%	-84.52%
Cash & Equivalents	$168.1K	$1.152M	$1.152M
Short-Term Investments
Other Short-Term Assets		$324.7K	$324.7K
YoY Change		-76.05%	-76.05%
Inventory			$0.00
Prepaid Expenses
Receivables	$25.40K	$103.3K	$103.3K
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$572.8K	$1.580M	$1.580M
YoY Change	-92.08%	-85.17%	-85.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.155M		$140.00
YoY Change	-69.99%		-100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$302.3K	$302.3K	$302.3K
YoY Change	-39.17%	-39.01%	-89.19%
Total Long-Term Assets	$2.297M	$302.4K	$302.4K
YoY Change	-84.9%	-98.0%	-98.0%
TOTAL ASSETS
Total Short-Term Assets	$572.8K	$1.580M	$1.580M
Total Long-Term Assets	$2.297M	$302.4K	$302.4K
Total Assets	$2.870M	$1.882M	$1.882M
YoY Change	-87.21%	-92.71%	-92.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$128.4K	$111.1K	$111.2K
YoY Change	-34.26%	-73.59%	-73.59%
Accrued Expenses	$565.3K	$135.5K	$411.0K
YoY Change	-45.81%	-91.12%	-86.31%
Deferred Revenue		$25.93K
YoY Change		-81.75%
Short-Term Debt		$0.00	$0.00
YoY Change
Long-Term Debt Due	$11.10M	$10.87M	$10.87M
YoY Change	20.76%	54.81%	54.74%
Total Short-Term Liabilities	$12.60M	$11.42M	$11.42M
YoY Change	1.48%	7.84%	7.84%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities			$2.022M
YoY Change			-27.67%
Total Long-Term Liabilities		$0.00	$2.022M
YoY Change		-100.0%	-73.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.60M	$11.42M	$11.42M
Total Long-Term Liabilities		$0.00	$2.022M
Total Liabilities	$14.54M	$13.44M	$13.44M
YoY Change	-6.66%	-26.28%	-26.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$306.8M	-$305.5M
YoY Change	7.87%	11.97%
Common Stock	$13.49K	$12.83K
YoY Change	-80.64%	-55.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.500M	-$11.56M	-$11.56M
YoY Change
Total Liabilities & Shareholders Equity	$2.870M	$1.882M	$1.882M
YoY Change	-87.21%	-92.71%	-92.71%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.576M	-$17.04M	-$32.67M
YoY Change	-72.95%	61.76%	-12.38%
Depreciation, Depletion And Amortization		$248.0K	$1.319M
YoY Change		-26.01%	-19.73%
Cash From Operating Activities		-$1.676M	-$14.32M
YoY Change		-58.03%	-29.98%
INVESTING ACTIVITIES
Capital Expenditures		$910.00	$800.4K
YoY Change		-99.77%	35.49%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$910.00	-$800.4K
YoY Change		-99.77%	35.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		2.098M	$8.373M
YoY Change		107.46%	-224.31%
NET CHANGE
Cash From Operating Activities		-1.676M	-$14.32M
Cash From Investing Activities		-910.0	-$800.4K
Cash From Financing Activities		2.098M	$8.373M
Net Change In Cash		420.4K	-$6.482M
YoY Change		-112.41%	-77.41%
FREE CASH FLOW
Cash From Operating Activities		-$1.676M	-$14.32M
Capital Expenditures		$910.00	$800.4K
Free Cash Flow		-$1.677M	-$15.12M
YoY Change		-61.87%	-28.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001293818
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2023Q4	us-gaap	Other Inventory Net Of Reserves OtherInventoryNetOfReserves		usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent		usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss		usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	opgn	Loss On Deconsolidation Of Subsidiaries LossOnDeconsolidationOfSubsidiaries		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023	opgn	Stock Issued During Period Share Cancellation Value StockIssuedDuringPeriodShareCancellationValue		usd
CY2023	opgn	Share Issuance ShareIssuance		usd
CY2022	opgn	Cash Bonus Taken In Form Of Stock Compensations CashBonusTakenInFormOfStockCompensations		usd
CY2022	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss		usd
CY2022	opgn	Impairment Of Property And Equipment ImpairmentOfPropertyAndEquipment		usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
CY2023	opgn	Proceeds From At Market Offering Net Of Issuance Costs ProceedsFromAtMarketOfferingNetOfIssuanceCosts		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants		usd
CY2022	opgn	Rightofuse Assets Acquired Through Operating Leases RightofuseAssetsAcquiredThroughOperatingLeases		usd
CY2022	opgn	Purchased Equipment Not Yet Paid For PurchasedEquipmentNotYetPaidFor		usd
CY2023	opgn	Property And Equipment Transferred To Inventory PropertyAndEquipmentTransferredToInventory		usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves		usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves		usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves		usd
CY2023Q4	us-gaap	Inventory Net InventoryNet		usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum		pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate		pure
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward		usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward		usd
CY2022Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	235974	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	950935	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10288	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-16000	usd
CY2023	opgn	Cash Bonus Taken In Form Of Stock Compensations CashBonusTakenInFormOfStockCompensations	-283554	usd
CY2023	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-12979061	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-64259	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-113740	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	849243	usd
CY2023	opgn	Impairment Of Property And Equipment ImpairmentOfPropertyAndEquipment	1231874	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5407699	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
CY2022	opgn	Operating Leases OperatingLeases		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	5681755	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1343739	shares
CY2023	dei	Auditor Firm AuditorFirmId	7116
CY2023	dei	Auditor Name AuditorName	Beckles & Co., Inc
CY2023	dei	Auditor Location AuditorLocation	West Palm Beach, Florida
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1151823	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7440030	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	103316	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	514372	usd
CY2022Q4	us-gaap	Other Inventory Net Of Reserves OtherInventoryNetOfReserves	1345137	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	324735	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1355949	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1579874	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	10655488	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3457531	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	138	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3500	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1459413	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7440974	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	2300614	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	302262	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	495629	usd
CY2023Q4	us-gaap	Assets Assets	1882274	usd
CY2022Q4	us-gaap	Assets Assets	25813149	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	111149	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	420821	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	127601	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1097654	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	135476	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1526204	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	25926	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	142061	usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	10873867	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	7023901	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	280	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3364	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	147943	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	377626	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11422242	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10591631	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4850686	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	99498	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	280	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2021616	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2566138	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	129368	usd
CY2023Q4	us-gaap	Liabilities Liabilities	13443858	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18237601	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	250	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	250	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	2500	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1282686	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1282686	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	289992	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	289992	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	12827	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2900	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	293991529	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	281193260	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-305493302	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-272824772	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-75138	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-795840	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11561584	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7575548	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1882274	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25813149	usd
CY2023	us-gaap	Revenues Revenues	3418320	usd
CY2022	us-gaap	Revenues Revenues	2607293	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3084075	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3319586	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	424939	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	104405	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4732851	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8173435	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8884084	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	849243	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1231874	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5407699	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2023	opgn	Loss On Deconsolidation Of Subsidiaries LossOnDeconsolidationOfSubsidiaries	-12979061	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	34166975	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	37174414	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-34567121	usd
CY2023	opgn	Interest And Other Income Net InterestAndOtherIncomeNet	142488	usd
CY2023	us-gaap	Interest Expense InterestExpense	1838933	usd
CY2022	us-gaap	Interest Expense InterestExpense	3256410	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-289306	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	379622	usd
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	65876	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	113741	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1919875	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2716112	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32668530	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37283233	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-41.47
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-41.47
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-152.70
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-152.70
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	787832	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	787832	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	244158	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	244158	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-32668530	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-37283233	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	720702	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1381466	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-31947828	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38664699	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41217080	usd
CY2022	opgn	Offering Of Common Stock And Warrants Net Of Issuance Costs OfferingOfCommonStockAndWarrantsNetOfIssuanceCosts	3082528	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	989704	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	950935	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1381466	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-37283233	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7575548	usd
CY2023	opgn	Offering Of Common Stock And Warrants Net Of Issuance Costs OfferingOfCommonStockAndWarrantsNetOfIssuanceCosts	12041168	usd
CY2023	opgn	Offering Of Preferred Stock And Warrants Net Of Issuance Costs OfferingOfPreferredStockAndWarrantsNetOfIssuanceCosts	250000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	235974	usd
CY2023	opgn	Cash Bonus Taken In Form Of Stock Compensation CashBonusTakenInFormOfStockCompensation	283554	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	720702	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-32668530	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11561584	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-32668530	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-37283233	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1318597	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1642781	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	1741422	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	2359219	usd
CY2023	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	797840	usd
CY2022	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	1582026	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	950935	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10288	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-16000	usd
CY2023	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-12979061	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-64259	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-113740	usd
CY2023	opgn	Impairment Of Property And Equipment ImpairmentOfPropertyAndEquipment	1231874	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5407699	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-39115	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-587761	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-748445	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	728548	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	259173	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-151456	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-24158	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-814299	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1612944	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1287874	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	74109	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	139570	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14319542	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20449698	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	800412	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-800412	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-590772	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	12041168	usd
CY2022	opgn	Proceeds From At Market Offering Net Of Issuance Costs ProceedsFromAtMarketOfferingNetOfIssuanceCosts	989704	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3082528	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	250000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	3914490	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	10764763	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3364	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	43150	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8373314	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6735681	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	265066	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-920376	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6481574	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-28696527	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7935659	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1454085	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7935659	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1424140	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1079113	usd
CY2023	opgn	Rightofuse Assets Acquired Through Operating Leases RightofuseAssetsAcquiredThroughOperatingLeases	801321	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-39115	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-587761	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-748445	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	728548	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	259173	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-151456	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-24158	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-814299	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1612944	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1287874	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	74109	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	139570	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14319542	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20449698	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	800412	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	590772	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-800412	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-590772	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	12041168	usd
CY2022	opgn	Proceeds From At Market Offering Net Of Issuance Costs ProceedsFromAtMarketOfferingNetOfIssuanceCosts	989704	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3082528	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	250000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	3914490	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	10764763	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3364	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	43150	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8373314	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6735681	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	265066	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-920376	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6481574	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-28696527	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7935659	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	36632186	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1454085	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7935659	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1424140	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1079113	usd
CY2023	opgn	Purchased Equipment Not Yet Paid For PurchasedEquipmentNotYetPaidFor	108715	usd
CY2022	opgn	Property And Equipment Transferred To Inventory PropertyAndEquipmentTransferredToInventory	152243	usd
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1089274	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	7.785
CY2023Q4	opgn	Additional Consideration Required AdditionalConsiderationRequired	0.25
CY2023	opgn	Common Shares Exercised CommonSharesExercised	200000	shares
CY2023Q4	opgn	Gross Proceeds From Issuance Of Common Stock GrossProceedsFromIssuanceOfCommonStock	2057000.000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1000
CY2023Q4	us-gaap	Investments Investments	250000	usd
CY2023Q4	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	1000000.0	usd
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3000000
CY2023Q2	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1000000
CY2023	opgn	Purchased Equipment Not Yet Paid For PurchasedEquipmentNotYetPaidFor	108715	usd
CY2022	opgn	Property And Equipment Transferred To Inventory PropertyAndEquipmentTransferredToInventory	152243	usd
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1089274	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	7.785
CY2023Q4	opgn	Additional Consideration Required AdditionalConsiderationRequired	0.25
CY2023	opgn	Common Shares Exercised CommonSharesExercised	200000	shares
CY2023Q4	opgn	Gross Proceeds From Issuance Of Common Stock GrossProceedsFromIssuanceOfCommonStock	2057000.000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1000
CY2023Q4	us-gaap	Investments Investments	250000	usd
CY2023Q4	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	1000000.0	usd
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3000000
CY2023Q2	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1000000
CY2023Q2	opgn	Proceeds From Equity Transaction ProceedsFromEquityTransaction	3500000	usd
CY2023Q2	opgn	Net Proceeds Issuance From Warrants NetProceedsIssuanceFromWarrants	3000000.0	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.785
CY2023Q4	opgn	Payment Of Additional Consideration Price PaymentOfAdditionalConsiderationPrice	0.25
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	639691	shares
CY2023Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	7.785
CY2023Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023Q2	opgn	Increase In Fair Value Resulting From Warrant Modification IncreaseInFairValueResultingFromWarrantModification	300000	usd
CY2023	opgn	Common Shares Exercised CommonSharesExercised	200000	shares
CY2023Q4	opgn	Gross Proceeds From Issuance Of Common Stock GrossProceedsFromIssuanceOfCommonStock	2057000.000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	26.50
CY2023Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	7.785
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26800	shares
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023	opgn	Warrant Expiry Period WarrantExpiryPeriod	five and one-half years
CY2022Q4	opgn	Increase In Fair Value From Warrant Modification IncreaseInFairValueFromWarrantModification	1800000	usd
CY2023Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	7.785
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-512458	usd
CY2023Q2	opgn	Net Proceeds Issuance From Warrants NetProceedsIssuanceFromWarrants	3000000.0	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.785
CY2023Q4	opgn	Payment Of Additional Consideration Price PaymentOfAdditionalConsiderationPrice	0.25
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	639691	shares
CY2023Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	7.785
CY2023Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023Q2	opgn	Increase In Fair Value Resulting From Warrant Modification IncreaseInFairValueResultingFromWarrantModification	300000	usd
CY2023	opgn	Common Shares Exercised CommonSharesExercised	200000	shares
CY2023Q4	opgn	Gross Proceeds From Issuance Of Common Stock GrossProceedsFromIssuanceOfCommonStock	2057000.000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	26.50
CY2023Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	7.785
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26800	shares
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	21500	shares
CY2023	opgn	Warrant Expiry Period WarrantExpiryPeriod	five and one-half years
CY2022Q4	opgn	Increase In Fair Value From Warrant Modification IncreaseInFairValueFromWarrantModification	1800000	usd
CY2023Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	7.785
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zNUA4MlhjcPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86E_zO7QYZfGB9Bi">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, liquidity assumptions, revenue recognition, inducement expense related to warrant repricing, stock-based compensation, allowances for doubtful accounts and inventory obsolescence, discount rates used to discount unpaid lease payments to present values, valuation of derivative financial instruments measured at fair value on a recurring basis, deferred tax assets and liabilities and related valuation allowance, the estimated useful lives of long-lived assets, and the recoverability of long-lived assets. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	302262	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	495629	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2022	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	5407699	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	624240	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zNUA4MlhjcPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86E_zO7QYZfGB9Bi">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, liquidity assumptions, revenue recognition, inducement expense related to warrant repricing, stock-based compensation, allowances for doubtful accounts and inventory obsolescence, discount rates used to discount unpaid lease payments to present values, valuation of derivative financial instruments measured at fair value on a recurring basis, deferred tax assets and liabilities and related valuation allowance, the estimated useful lives of long-lived assets, and the recoverability of long-lived assets. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	302262	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	495629	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1151823	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7440030	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	302262	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	495629	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1454085	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7935659	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	725060	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1151823	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7440030	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	302262	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	495629	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1454085	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7935659	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1011476	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	37445	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2596830	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3645751	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1280805	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1694843	usd
CY2023	opgn	Estimated Service Lives Description EstimatedServiceLivesDescription	The estimated service lives range from three to ten years.
CY2023	us-gaap	Depreciation Depreciation	584230	usd
CY2022	us-gaap	Depreciation Depreciation	830757	usd
CY2022Q4	us-gaap	Goodwill Goodwill	-0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	99498	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7453007	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1011476	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	37445	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2596830	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3645751	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1280805	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1694843	usd
CY2023	us-gaap	Depreciation Depreciation	584230	usd
CY2022	us-gaap	Depreciation Depreciation	830757	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1464849	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7518811	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	1464849	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	4061280	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3457531	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1231874	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	849243	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15518000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-15508176	usd
CY2023Q4	opgn	Effects Of Foreign Exchange Rates EffectsOfForeignExchangeRates	-9824	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-7437206	usd
CY2022Q4	opgn	Effects Of Foreign Exchange Rates EffectsOfForeignExchangeRates	-639820	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7440974	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1464849	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7518811	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	1464849	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	4061280	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3457531	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1231874	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	849243	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15518000	usd
CY2023Q4	opgn	Effects Of Foreign Exchange Rates EffectsOfForeignExchangeRates	-9824	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-7437206	usd
CY2022Q4	opgn	Effects Of Foreign Exchange Rates EffectsOfForeignExchangeRates	-639820	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7440974	usd
CY2022	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	5407699	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	624240	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	725060	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7453007	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-512458	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2022Q4	us-gaap	Goodwill Goodwill	-0	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-65876	usd
CY2023	opgn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Effect Of Foreign Exchange Rates FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchangeRates	-33622	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	228589	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	99498	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-65876	usd
CY2023	opgn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Effect Of Foreign Exchange Rates FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchangeRates	-33622	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	228589	usd
CY2023	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	301575	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	424304	usd
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	0	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	401436	usd
CY2023	opgn	Tax Benefit Percentage TaxBenefitPercentage	0.50	pure
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	241110447	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	232682072	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1200000	shares
CY2023	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	301575	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	424304	usd
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	0	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	401436	usd
CY2023	opgn	Tax Benefit Percentage TaxBenefitPercentage	0.50	pure
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	241110447	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	232682072	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1200000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.785
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60500	shares
CY2023Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q2	opgn	Prefunded Warrants In Shares PrefundedWarrantsInShares	389083	shares
CY2023Q2	opgn	Prefunded Warrants In Shares PrefundedWarrantsInShares	389083	shares
CY2023	us-gaap	Revenues Revenues	3418320	usd
CY2022	us-gaap	Revenues Revenues	2607293	usd
CY2023	us-gaap	Revenues Revenues	3418320	usd
CY2022	us-gaap	Revenues Revenues	2607293	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	142061	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	142061	usd
CY2023	us-gaap	Contract With Customer Asset Purchase ContractWithCustomerAssetPurchase	74109	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-144196	usd
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-46048	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25926	usd
CY2023	us-gaap	Revenues Revenues	3418320	usd
CY2022	us-gaap	Revenues Revenues	2607293	usd
CY2023	us-gaap	Revenues Revenues	3418320	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	142061	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	142061	usd
CY2023	us-gaap	Contract With Customer Asset Purchase ContractWithCustomerAssetPurchase	74109	usd
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-46048	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25926	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-113741	usd
CY2022	opgn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Effect Of Foreign Exchange Rates FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityEffectOfForeignExchangeRates	-15350	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	99498	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1231874	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	849243	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6940549	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5407699	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	10873867	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	13489178	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1614591	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	10873867	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	11874587	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10873867	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7023901	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	4850686	usd
CY2017Q2	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.04	pure
CY2019Q2	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	5000000.0
CY2019Q2	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	5000000.0
CY2022Q2	us-gaap	Payments For Loans PaymentsForLoans	700000
CY2023Q2	opgn	Aggrement Amount Paid AggrementAmountPaid	1000000
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	1838933	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	3256410	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1282686	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	250	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	250	shares
CY2022	opgn	Sale Of Stock Number Of Share Issued In Transaction SaleOfStockNumberOfShareIssuedInTransaction	8574	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26800	shares
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2022Q4	opgn	Prefunded Warrants In Shares PrefundedWarrantsInShares	21500	shares
CY2022Q4	opgn	Net Proceeds From Issuance Of Common Stock NetProceedsFromIssuanceOfCommonStock	3040000.00	usd
CY2023	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	provide that the existing warrants, as amended, will not be exercisable until six months following the closing date of the offering
CY2023	opgn	Common Warrant Expiration Date CommonWarrantExpirationDate	expiration date of the existing warrants by five and one-half years
CY2022Q4	opgn	Exercised Warrants ExercisedWarrants	33810	shares
CY2023Q1	opgn	Exercise Price Of Common Warrants ExercisePriceOfCommonWarrants	26.50
CY2023Q1	opgn	Exercise Price Of Pre Funded Warrants ExercisePriceOfPreFundedWarrants	0.10
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-113741	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1231874	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	849243	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5407699	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	10873867	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	13489178	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1614591	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	10873867	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	11874587	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10873867	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7023901	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	4850686	usd
CY2017Q2	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.04	pure
CY2019Q2	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	5000000.0
CY2019Q2	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	5000000.0
CY2022Q2	us-gaap	Payments For Loans PaymentsForLoans	700000
CY2023Q2	opgn	Aggrement Amount Paid AggrementAmountPaid	1000000
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	1838933	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	3256410	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1282686	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1282686	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	250	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	250	shares
CY2022	opgn	Sale Of Stock Number Of Share Issued In Transaction SaleOfStockNumberOfShareIssuedInTransaction	8574	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26800	shares
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2022Q4	opgn	Prefunded Warrants In Shares PrefundedWarrantsInShares	21500	shares
CY2022Q4	opgn	Net Proceeds From Issuance Of Common Stock NetProceedsFromIssuanceOfCommonStock	3040000.00	usd
CY2023	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	provide that the existing warrants, as amended, will not be exercisable until six months following the closing date of the offering
CY2023	opgn	Common Warrant Expiration Date CommonWarrantExpirationDate	expiration date of the existing warrants by five and one-half years
CY2022Q4	opgn	Exercised Warrants ExercisedWarrants	33810	shares
CY2023Q1	opgn	Exercise Price Of Common Warrants ExercisePriceOfCommonWarrants	26.50
CY2023Q1	opgn	Exercise Price Of Pre Funded Warrants ExercisePriceOfPreFundedWarrants	0.10
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.785
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60500	shares
CY2023Q2	opgn	Common Warrants Issued CommonWarrantsIssued	449583	shares
CY2023Q2	opgn	Price Per Share Of Common Stock And Accompanying Common Warrant PricePerShareOfCommonStockAndAccompanyingCommonWarrant	7.785
CY2023Q2	opgn	Price Per Share Of Prefunded Warrant And Common Warrant PricePerShareOfPrefundedWarrantAndCommonWarrant	7.685
CY2023Q2	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3500000	usd
CY2023Q2	opgn	Net Proceeds From Issuance Of Common Stock NetProceedsFromIssuanceOfCommonStock	3000000.0	usd
CY2023Q2	opgn	Exercise Price Of Common Warrants ExercisePriceOfCommonWarrants	7.785
CY2023Q2	opgn	Number Of Repriced Warrants To Purchase Shares NumberOfRepricedWarrantsToPurchaseShares	639691	shares
CY2023Q4	opgn	Number Of Warrants Exercised In Shares NumberOfWarrantsExercisedInShares	200000	shares
CY2023Q4	opgn	Gross Proceeds For Warrant Inducement GrossProceedsForWarrantInducement	2057000.000	usd
CY2023Q4	opgn	Shares Of Series D Preferred Stock For Sale SharesOfSeriesDPreferredStockForSale	1000
CY2023Q4	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1000000.0	usd
CY2023Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	1000
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q4	us-gaap	Share Price SharePrice	4.09
CY2023Q4	opgn	Affiliates Holding Percentage AffiliatesHoldingPercentage	0.1999	pure
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	250	shares
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q4	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	1089274	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	7.785
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	1	pure
CY2023Q4	opgn	Number Of Warrants Exercised In Shares NumberOfWarrantsExercisedInShares	200000	shares
CY2023Q4	opgn	Gross Proceeds For Warrant Inducement GrossProceedsForWarrantInducement	2057000.000	usd
CY2023	opgn	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	235974	usd
CY2022	opgn	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	950935	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8567	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1376.00
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P8Y6M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2813	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	156.10
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	324	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	311.10
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	295	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6417.80
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10761	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	934.50
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	420	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	299.80
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	717	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1012.10
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9624	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1064.84
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2023Q2	opgn	Common Warrants Issued CommonWarrantsIssued	449583	shares
CY2023Q2	opgn	Price Per Share Of Common Stock And Accompanying Common Warrant PricePerShareOfCommonStockAndAccompanyingCommonWarrant	7.785
CY2023Q2	opgn	Price Per Share Of Prefunded Warrant And Common Warrant PricePerShareOfPrefundedWarrantAndCommonWarrant	7.685
CY2023Q2	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3500000	usd
CY2023Q2	opgn	Net Proceeds From Issuance Of Common Stock NetProceedsFromIssuanceOfCommonStock	3000000.0	usd
CY2023Q2	opgn	Exercise Price Of Common Warrants ExercisePriceOfCommonWarrants	7.785
CY2023Q2	opgn	Number Of Repriced Warrants To Purchase Shares NumberOfRepricedWarrantsToPurchaseShares	639691	shares
CY2023Q4	opgn	Number Of Warrants Exercised In Shares NumberOfWarrantsExercisedInShares	200000	shares
CY2023Q4	opgn	Gross Proceeds For Warrant Inducement GrossProceedsForWarrantInducement	2057000.000	usd
CY2023Q4	opgn	Shares Of Series D Preferred Stock For Sale SharesOfSeriesDPreferredStockForSale	1000
CY2023Q4	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1000000.0	usd
CY2023Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	1000
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q4	us-gaap	Share Price SharePrice	4.09
CY2023Q4	opgn	Affiliates Holding Percentage AffiliatesHoldingPercentage	0.1999	pure
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	250	shares
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q4	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	1089274	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	7.785
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	1	pure
CY2023Q4	opgn	Number Of Warrants Exercised In Shares NumberOfWarrantsExercisedInShares	200000	shares
CY2023Q4	opgn	Gross Proceeds For Warrant Inducement GrossProceedsForWarrantInducement	2057000.000	usd
CY2023	opgn	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	235974	usd
CY2022	opgn	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	950935	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8567	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1376.00
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P8Y6M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2813	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	156.10
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	324	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	311.10
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	295	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6417.80
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10761	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	934.50
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	420	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	299.80
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	717	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1012.10
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9624	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1064.84
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	9624	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	9624	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1064.84
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7433	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1378.72
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y1M6D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	646606	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	571282	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1095517	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	129125	shares
CY2023	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	32700000	usd
CY2022	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	37300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	110664601	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	106624343	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	110358421	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	89055237	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	102095463	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2559479	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2559479	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	729693	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	724265	usd
CY2023Q4	opgn	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	553374	usd
CY2022Q4	opgn	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	586067	usd
CY2023Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	17161363	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	605455	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	659069	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	110664601	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1064.84
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7433	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1378.72
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y1M6D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	646606	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	571282	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1095517	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	129125	shares
CY2023	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	32700000	usd
CY2022	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	37300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	110664601	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	106624343	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	110358421	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	106060462	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	89055237	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	102095463	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2559479	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2559479	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	729693	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	724265	usd
CY2023Q4	opgn	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	553374	usd
CY2022Q4	opgn	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	586067	usd
CY2023Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	17161363	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	605455	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	659069	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	110664601	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	106624343	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	110358421	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	106060462	usd
CY2023Q4	opgn	Deferred Tax Assets Operating Lease Right Of Use Asset DeferredTaxAssetsOperatingLeaseRightOfUseAsset	-35	usd
CY2022Q4	opgn	Deferred Tax Assets Operating Lease Right Of Use Asset DeferredTaxAssetsOperatingLeaseRightOfUseAsset	-220040	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	306145	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	343841	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.005	pure
CY2023	opgn	Effective Income Tax Rate Reconciliation Provision To Return Adjustment EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustment	0.002	pure
CY2022	opgn	Effective Income Tax Rate Reconciliation Provision To Return Adjustment EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustment	0.005	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.107	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.022	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.116	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.038	pure
CY2023	opgn	Lost Or Expired No Lsin Shares LostOrExpiredNOLsinShares	-0.070	pure
CY2022	opgn	Lost Or Expired No Lsin Shares LostOrExpiredNOLsinShares	-0.284	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.013	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.132	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	110400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	106100000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	241110447	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	232682072	usd
CY2023	opgn	Tax Cuts And Jobs Act Of2017 Maximum Percentage Of Taxable Income In Which Operating Loss Permitted To Deduct TaxCutsAndJobsActOf2017MaximumPercentageOfTaxableIncomeInWhichOperatingLossPermittedToDeduct	0.80	pure
CY2023	opgn	Performed Outside PerformedOutside	P15Y
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	23000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	106624343	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	110358421	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	106060462	usd
CY2023Q4	opgn	Deferred Tax Assets Operating Lease Right Of Use Asset DeferredTaxAssetsOperatingLeaseRightOfUseAsset	-35	usd
CY2022Q4	opgn	Deferred Tax Assets Operating Lease Right Of Use Asset DeferredTaxAssetsOperatingLeaseRightOfUseAsset	-220040	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	306145	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	343841	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.005	pure
CY2023	opgn	Effective Income Tax Rate Reconciliation Provision To Return Adjustment EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustment	0.002	pure
CY2022	opgn	Effective Income Tax Rate Reconciliation Provision To Return Adjustment EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustment	0.005	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.107	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.022	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.116	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.038	pure
CY2023	opgn	Lost Or Expired No Lsin Shares LostOrExpiredNOLsinShares	-0.070	pure
CY2022	opgn	Lost Or Expired No Lsin Shares LostOrExpiredNOLsinShares	-0.284	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.013	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.132	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	110400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	106100000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	241110447	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	232682072	usd
CY2023	opgn	Tax Cuts And Jobs Act Of2017 Maximum Percentage Of Taxable Income In Which Operating Loss Permitted To Deduct TaxCutsAndJobsActOf2017MaximumPercentageOfTaxableIncomeInWhichOperatingLossPermittedToDeduct	0.80	pure
CY2023	opgn	Performed Outside PerformedOutside	P15Y
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	23000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1459413	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	138	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3500	usd
CY2023Q4	opgn	Lease Right Of Use Asset LeaseRightOfUseAsset	138	usd
CY2022Q4	opgn	Lease Right Of Use Asset LeaseRightOfUseAsset	1462913	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	147943	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	377626	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	280	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3364	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2021616	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2566138	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	280	usd
CY2023Q4	opgn	Lease Liability LeaseLiability	2169839	usd
CY2022Q4	opgn	Lease Liability LeaseLiability	2947408	usd
CY2023Q4	opgn	Operating And Finance Lease Liability Payments Remainder Of Fiscal Year OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	358628	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	368179	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	378279	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	388682	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	399388	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1338300	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3231456	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1061617	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2169839	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1459413	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	138	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3500	usd
CY2023Q4	opgn	Lease Right Of Use Asset LeaseRightOfUseAsset	138	usd
CY2022Q4	opgn	Lease Right Of Use Asset LeaseRightOfUseAsset	1462913	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	147943	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	280	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3364	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2021616	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2566138	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	280	usd
CY2023Q4	opgn	Lease Liability LeaseLiability	2169839	usd
CY2022Q4	opgn	Lease Liability LeaseLiability	2947408	usd
CY2023Q4	opgn	Operating And Finance Lease Liability Payments Remainder Of Fiscal Year OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	358628	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	368179	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	378279	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	388682	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	399388	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1338300	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3231456	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1061617	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2169839	usd
CY2023	us-gaap	Lease Cost LeaseCost	585363	usd
CY2022	us-gaap	Lease Cost LeaseCost	693807	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M12D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.100	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.010	pure
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	582001	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	605139	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1701	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3364	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	43150	usd
CY2023	opgn	Operating Leases OperatingLeases	801321	usd
CY2023	us-gaap	Lease Cost LeaseCost	585363	usd
CY2022	us-gaap	Lease Cost LeaseCost	693807	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M12D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.100	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.010	pure
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	582001	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	605139	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1701	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3364	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	43150	usd
CY2023	opgn	Operating Leases OperatingLeases	801321	usd

Files In Submission

Name	View Source	Status
0001829126-24-003930-index-headers.html	Edgar Link	pending
0001829126-24-003930-index.html	Edgar Link	pending
0001829126-24-003930.txt	Edgar Link	pending
0001829126-24-003930-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opgeninc_10k.htm	Edgar Link	pending
opgeninc_ex19.htm	Edgar Link	pending
opgeninc_ex21-1.htm	Edgar Link	pending
opgeninc_ex23-1.htm	Edgar Link	pending
opgeninc_ex23-2.htm	Edgar Link	pending
opgeninc_ex31-1.htm	Edgar Link	pending
opgeninc_ex32-1.htm	Edgar Link	pending
opgeninc_ex97-1.htm	Edgar Link	pending
opgn-20231231.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
opgn-20231231_cal.xml	Edgar Link	unprocessable
opgn-20231231_def.xml	Edgar Link	unprocessable
opgn-20231231_lab.xml	Edgar Link	unprocessable
opgeninc_10k_htm.xml	Edgar Link	completed
opgn-20231231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPGN
OPGEN INC Stock $opgn

2024 Q2 Form 10-K Financial Statement

#000182912624003930 Filed on June 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPGN OPGEN INC Stock $opgn

2024 Q2 Form 10-K Financial Statement

#000182912624003930 Filed on June 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPGN
OPGEN INC Stock $opgn